Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17943286 | 0.86 | SNCA (0.36) | LPLLIPGSNCA | |
| SCHEMBL14052906 | 0.83 | SNCA (0.38) | LPLLIPGSNCAALDH1A1TSHR | |
| SCHEMBL2274567 | 0.81 | LPL (0.42) | LPLLIPGSNCA | |
| SCHEMBL4264297 | 0.79 | SNCA (0.44) | LPLLIPGSNCAF11 | |
| SCHEMBL26648626 | 0.78 | LIPG (0.59) | LPLLIPGSNCAALDH1A1MAPK1 | |
| SCHEMBL18339194 | 0.78 | NR1H2 (0.46) | — | |
| SCHEMBL16382771 | 0.78 | SNCA (0.43) | LPLLIPGSNCACCR6KCNH2 | |
| SCHEMBL17940673 | 0.78 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL15300654 | 0.77 | HSD11B1 (0.38) | SNCA | |
| SCHEMBL2949055 | 0.76 | SNCA (0.37) | SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802963-B2 | Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same | DAIKIN INDUSTRIES, LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20160214999-A1 | FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2016-07-28 | — | — | US | disclosed |
| WO-2015050236-A1 | FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME | ダイキン工業株式会社 | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160214999-A1 | FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME | AFF1, AFF2, AFF4 | LPL 4234/4885LIPG 4848/4885SNCA 1133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.